| 17q23-q25.3 | * Sodium-channel myasthenia - (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Severe foetal hypokinesia related to SCN4A - (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Paramyotonia congenita of Von Eulenburg - PMC (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Hyperkalemic periodic paralysis - HYPP (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Potassium-aggravated myotonia - (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Myotonia potassium-aggravatd - (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Hyperkalemic periodic paralysis, type 2 - HOKPP2 (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Myasthenic syndrome, acetazolamide-responsive - (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Myasthenic syndrome, congenital, 16 - CMS16 (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Congenital Myopathy 22A, classic - CMYP22A (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33) * Congenital Myopathy 22B, severe fetal - CMYP22B (3.48, 3.49, 7.3, 7.4, 7.6, 7.7, 11.24, 16.33)
|